Over 600 people set to benefit from innovative lung cancer treatment within the Cancer Drugs Fund
More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the Cancer Drugs Fund.
-
NICE creates new menu of treatment options for those suffering from depression
People with depression should make the choice on what treatment option is right for them, in discussion with their healthcare professional, NICE says in new draft guidance.
-
NICE draft guidance recommends new treatment for spinal muscular atrophy as part of a managed access agreement
Around 1,500 people in England with the rare genetic disorder spinal muscular atrophy are set to benefit from a new treatment after NICE today (19 November 2021) published draft guidance recommending risdiplam (also called Evrysdi and made by Roche) as part of a managed access agreement (MAA).
-
NICE approves first long-acting injectable HIV-1 treatment
NICE has today (18 November 2021) published draft guidance recommending the first long-acting injectable treatment for HIV-1 infection in adults.
